Question

Difficulty: MediumImmunologic and Inflammatory Processes

A physician evaluates an ambulatory patient who recently developed a progressively worsening rash on both lower extremities. The patient also reports significant new-onset fatigue and bilateral pain in the metacarpophalangeal and knee joints over the past 1414 days. Medical history is significant for a diagnosis of chronic hepatitis C virus (HCV) infection confirmed several years ago, though the patient has not undergone any targeted antiviral treatment. On physical examination, the physician notes multiple non-blanching, raised, red-purple lesions distributed over the shins and calves. Joint examination shows mild, symmetric swelling without warmth. Laboratory analysis demonstrates the following:

Serum aspartate aminotransferase: 8585 U/L
Serum alanine aminotransferase: 9292 U/L
Rheumatoid factor: Positive
Complement C3: Normal
Complement C4: Markedly decreased
Urinalysis: 2+2+ protein, 1515-2020 red blood cells/hpf, occasional dysmorphic red blood cells

Which of the following immunopathologic mechanisms is most likely responsible for this patient's current clinical presentation?

  1. A
    Autoantibody binding to platelet surface glycoproteins with subsequent splenic macrophage destruction
  2. B
    Neutrophil activation by autoantibodies directed against cytoplasmic lysosomal enzymes
  3. Precipitation and vessel wall deposition of circulating immune complexes containing IgG and IgMAnswer
  4. D
    Systemic activation of the coagulation cascade resulting in microvascular fibrin thrombi
  5. E
    Transmural inflammation and fibrinoid necrosis of medium-sized muscular arteries

Answer

Precipitation and vessel wall deposition of circulating immune complexes containing IgG and IgM
The correct answer accurately describes the pathophysiology of mixed cryoglobulinemia syndrome, a Type III hypersensitivity reaction. Chronic hepatitis C virus (HCV) infection provides continuous antigenic stimulation, leading to B-cell hyperactivation and the production of monoclonal or polyclonal IgM autoantibodies that possess rheumatoid factor activity. These IgM antibodies bind to the Fc portion of circulating IgG, forming immune complexes that precipitate in the cooler microvasculature of the skin, joints, and kidneys. Upon deposition in the vessel walls, these complexes aggressively activate the classical complement pathway, which preferentially consumes C4 (resulting in low serum levels while C3 often remains normal) and recruits neutrophils, ultimately causing the observed palpable purpura, arthralgias, and glomerulonephritis.

Step-by-Step Solution

1
Analyze the patient's clinical signs and risk factors.
The patient exhibits the classic triad of palpable purpura, arthralgias, and weakness, set against a background of chronic, untreated hepatitis C virus (HCV) infection.
Identifying the clinical syndrome is the first step toward recognizing the specific underlying immunologic derangement.
2
Interpret the laboratory findings.
The presence of positive rheumatoid factor, markedly low C4 with normal C3, and active urinary sediment (proteinuria, dysmorphic RBCs indicating glomerulonephritis) strongly confirm a diagnosis of mixed cryoglobulinemia syndrome.
These specific laboratory markers distinguish mixed cryoglobulinemia from other forms of systemic vasculitis or coagulopathy.
3
Connect the diagnosis to its fundamental immunopathologic mechanism.
Mixed cryoglobulinemia is driven by circulating immune complexes consisting of rheumatoid factor (IgM) binding to the Fc portion of IgG.
The deposition of these IgG-IgM complexes in small blood vessels triggers complement activation (consuming C4) and local inflammation, characteristic of a Type III hypersensitivity reaction.

Key Concept

Mixed cryoglobulinemia syndrome is a Type III hypersensitivity reaction strongly associated with chronic Hepatitis C infection. It is driven by the precipitation of circulating IgM-IgG immune complexes in small vessels, triggering classical complement activation and marked C4 consumption.
Rate this question